Your browser doesn't support javascript.
loading
Bleeding outcomes associated with rivaroxaban and dabigatran in patients treated for atrial fibrillation: a systematic review and meta-analysis.
Bundhun, Pravesh Kumar; Soogund, Mohammad Zafooruddin Sani; Teeluck, Abhishek Rishikesh; Pursun, Manish; Bhurtu, Akash; Huang, Wei-Qiang.
Afiliação
  • Bundhun PK; Institute of Cardiovascular Diseases, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530027, People's Republic of China.
  • Soogund MZ; Guangxi Medical University, Nanning, Guangxi, 530027, People's Republic of China.
  • Teeluck AR; Guangxi Medical University, Nanning, Guangxi, 530027, People's Republic of China.
  • Pursun M; Guangxi Medical University, Nanning, Guangxi, 530027, People's Republic of China.
  • Bhurtu A; Guangxi Medical University, Nanning, Guangxi, 530027, People's Republic of China.
  • Huang WQ; Institute of Cardiovascular Diseases, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, People's Republic of China. huangwq1029@126.com.
BMC Cardiovasc Disord ; 17(1): 15, 2017 01 06.
Article em En | MEDLINE | ID: mdl-28056795

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Acidente Vascular Cerebral / Prevenção Secundária / Rivaroxabana / Dabigatrana / Hemorragia Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Acidente Vascular Cerebral / Prevenção Secundária / Rivaroxabana / Dabigatrana / Hemorragia Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article